MARKSANS PHARMA
Back to Balance Sheet
|
MARKSANS PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | - | - | ₹1.45 Cr | ₹1.45 Cr | ₹20 Cr |
What is the latest Contingent Liabilities ratio of MARKSANS PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | ₹1.45 Cr |
| Mar2022 | ₹1.45 Cr |
| Mar2021 | ₹20 Cr |
How is Contingent Liabilities of MARKSANS PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | -100.00 | |
| Mar2023 | ₹1.45 Cr | 0.00 | |
| Mar2022 | ₹1.45 Cr | -92.68 | |
| Mar2021 | ₹20 Cr | - | |
Compare Contingent Liabilities of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹7,407.6 Cr | 0.2% | -9.1% | -36.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹382,694.0 Cr | -2.3% | -7.3% | -12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,721.0 Cr | 0.8% | -5.8% | 4.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,016.0 Cr | 0.8% | 3.7% | 20.8% | Stock Analytics | |
| CIPLA | ₹106,946.0 Cr | 0.7% | -11.2% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,691.0 Cr | -1.4% | -3.8% | -1.3% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 0.2% |
-9.1% |
-36.3% |
| SENSEX | -0.1% |
-2.9% |
7.5% |
You may also like the below Video Courses